1. Home
  2. RMT vs KURA Comparison

RMT vs KURA Comparison

Compare RMT & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Micro-Cap Trust Inc.

RMT

Royce Micro-Cap Trust Inc.

HOLD

Current Price

$13.81

Market Cap

722.0M

Sector

Finance

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$11.28

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMT
KURA
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.0M
841.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RMT
KURA
Price
$13.81
$11.28
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$25.56
AVG Volume (30 Days)
99.6K
1.6M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
7.37%
N/A
EPS Growth
N/A
N/A
EPS
1.49
N/A
Revenue
N/A
$67,482,000.00
Revenue This Year
N/A
$28.28
Revenue Next Year
N/A
$106.37
P/E Ratio
$9.04
N/A
Revenue Growth
N/A
25.24
52 Week Low
$8.66
$5.45
52 Week High
$13.97
$12.49

Technical Indicators

Market Signals
Indicator
RMT
KURA
Relative Strength Index (RSI) 65.61 72.07
Support Level $10.32 $8.80
Resistance Level $13.97 $12.41
Average True Range (ATR) 0.27 0.58
MACD -0.04 0.19
Stochastic Oscillator 88.08 92.39

Price Performance

Historical Comparison
RMT
KURA

About RMT Royce Micro-Cap Trust Inc.

Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector, including diversified consumer services, hotels, household durables, leisure products, and luxury goods. Consumer staples sector, including beverages, food, and staples retailing, food products, and personal products, Energy sector, including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors, including healthcare, financials, industrials, IT, telecommunications, and materials.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: